ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,587.00
0.23%
S&P ASX All Technology
2,972.40
0.12%
Brent Oil
84.175
0.76%
US Dollar vs AUD
1.53283
0.12%
Bitcoin
57,706.23
-0.91%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Mirum Pharmaceuticals Inc (MIRM)

  7. Mirum Pharmaceuticals Inc (MIRM) News

MIRM Mirum Pharmaceuticals Inc

25.72
0.00 (0.00%)
Pre Market
Last Updated: 18:05:22
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Mirum Pharmaceuticals Inc MIRM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 25.72 18:05:22
Open Price Low Price High Price Close Price Previous Close
25.72
more quote information »

Recent News

Date Time Source Heading
02/5/202406:10BWMirum Pharmaceuticals to Announce First Quarter 2024..
11/4/202411:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
02/4/202423:30BWMirum Pharmaceuticals’ LIVMARLI (maralixibat oral solution)..
25/3/202422:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
14/3/202409:00BWMirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for..
09/3/202411:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
06/3/202400:00BWMirum Pharmaceuticals to Participate in Upcoming Investor..
01/3/202400:30BWHepatology Publishes Six-Year Data Demonstrating Improved..
29/2/202409:01EDGAR2Form NT 10-K - Notification of inability to timely file Form..
29/2/202408:05EDGAR2Form 8-K - Current report
29/2/202408:03BWMirum Pharmaceuticals Reports Fourth Quarter and Year-End..
22/2/202408:05BWMirum Pharmaceuticals to Announce Fourth Quarter and..
10/2/202413:15BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
06/2/202413:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202413:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202413:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202411:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202411:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202411:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202413:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
17/1/202408:15EDGAR2Form 8-K - Current report
17/1/202400:30BWMirum Pharmaceuticals Appoints Joanne Quan, MD as Chief..
11/1/202411:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
10/1/202412:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202412:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202412:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:30EDGAR2Form 8-K - Current report
09/1/202400:30BWMirum Pharmaceuticals Announces Preliminary Unaudited 2023..
04/1/202400:45BWMirum Pharmaceuticals to Present at the 42nd Annual J.P...
19/12/202308:06EDGAR2Form 8-K - Current report
19/12/202300:30BWMirum Pharmaceuticals Announces Data from EMBARK Phase 2b..
09/12/202311:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
07/12/202309:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202316:00BWLIVMARLI (maralixibat) di Mirum Pharmaceutical è stato..
21/11/202308:05BWMirum Pharmaceuticals to Present at the 2023 Evercore ISI..
16/11/202312:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202312:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202306:00BWMirum Pharmaceuticals Presents New Data at The Liver..
11/11/202309:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
03/11/202323:30BWMirum Pharmaceuticals to Present at the 2023 UBS Biopharma..
03/11/202308:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/11/202307:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/11/202307:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202307:06EDGAR2Form 8-K - Current report
03/11/202307:05EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202307:05BWMirum Pharmaceuticals Reports Third Quarter 2023 Financial..
30/10/202323:30BWMirum Pharmaceuticals to Present New Data at The Liver..
27/10/202323:45BWMirum Pharmaceuticals to Announce Third Quarter 2023..
18/10/202307:39EDGAR2Form 8-K - Current report
18/10/202307:30BWMirum Pharmaceuticals Announces New PDUFA Date for LIVMARLI..

Your Recent History

NASDAQ
MIRM
Mirum Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved